India News | Press Trust of India | Wednesday March 31, 2021
The Drugs Controller General of India or DCGI, India's drug regulator, has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from six to nine months from its manufacturing date.
www.ndtv.com